Viewing nowCombinationEnpistar Tablets 40/5mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 201605822 · Approved 2016.09.30 · Insurance code 669906990
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively manage essential hypertension when blood pressure is not sufficiently controlled with telmisartan or amlodipine monotherapy.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, a direct switch to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.
This drug may pose serious risks to the fetus or newborn during pregnancy, especially in the second and third trimesters, and should not be taken by women who are pregnant or may become pregnant. People allergic to the active ingredients or similar substances, those with severe liver impairment, hypotension, or heart function issues should not take this medication. Patients with impaired liver or kidney function, the elderly, or patients with certain heart diseases should use this drug more cautiously and be monitored carefully according to a physician's instructions. When taking this medication, side effects such as dizziness, swelling, or hypotension may occur; if symptoms are severe, immediate consultation with a healthcare professional is necessary. It is crucial to monitor blood pressure and heart conditions regularly during treatment, especially since the medication can lower blood pressure too much or cause heart problems. This drug may interact with other medications, so inform your doctor or pharmacist about any current medications you are taking. Women who are pregnant or breastfeeding should not take this medication and should stop taking it immediately and consult a physician if pregnancy is planned or confirmed. The safety and efficacy have not been established for use in children, so its use is not recommended in this age group. In case of overdose, there is a risk of hypotension, dizziness, or heart function decline, requiring immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that does not allow light in. Additionally, it should be stored at room temperature, between 1 to 30 degrees Celsius, away from extremes of heat or cold to maintain effectiveness.
This is a biconvex, oval double tablet that is white and light gray.
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daehan New Pharm Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.